Natus Medical Inc (BABY) : Eagle Asset Management Inc reduced its stake in Natus Medical Inc by 3.87% during the most recent quarter end. The investment management company now holds a total of 2,882,163 shares of Natus Medical Inc which is valued at $113,758,974 after selling 116,144 shares in Natus Medical Inc , the firm said in a disclosure report filed with the SEC on Jul 19, 2016.Natus Medical Inc makes up approximately 0.76% of Eagle Asset Management Inc’s portfolio.
Other Hedge Funds, Including , Capital One National Association sold out all of its stake in BABY during the most recent quarter. The investment firm sold 9,673 shares of BABY which is valued $381,793. Anderson Hoagland Co added BABY to its portfolio by purchasing 41,565 company shares during the most recent quarter which is valued at $1,640,571. Natus Medical Inc makes up approx 1.00% of Anderson Hoagland Co’s portfolio. Eqis Capital Management sold out all of its stake in BABY during the most recent quarter. The investment firm sold 6,180 shares of BABY which is valued $248,745.Fisher Asset Management boosted its stake in BABY in the latest quarter, The investment management firm added 365 additional shares and now holds a total of 589,798 shares of Natus Medical Inc which is valued at $23,987,085. Natus Medical Inc makes up approx 0.05% of Fisher Asset Management’s portfolio.Bnp Paribas Arbitrage Sa boosted its stake in BABY in the latest quarter, The investment management firm added 5,643 additional shares and now holds a total of 10,316 shares of Natus Medical Inc which is valued at $409,029.
Natus Medical Inc closed down -0.83 points or -2.06% at $39.47 with 9,48,478 shares getting traded on Wednesday. Post opening the session at $40.83, the shares hit an intraday low of $38.905 and an intraday high of $41.28 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.
Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.